Skip to main content Accessibility help
×
Hostname: page-component-7b7567c8c-48dgx Total loading time: 0 Render date: 2026-11-18T02:51:01.883Z Has data issue: false hasContentIssue false

Chapter 7 - Fetal and neonatal alloimmune thrombocytopenia

from Section 2 - Fetal disease

Published online by Cambridge University Press:  05 February 2013

Mark D. Kilby
Affiliation:
Department of Fetal Medicine, University of Birmingham
Anthony Johnson
Affiliation:
Baylor College of Medicine, Texas
Dick Oepkes
Affiliation:
Department of Obstetrics, Leiden University Medical Center
Get access

Summary

Introduction

Fetal thrombocytopenia is a rare but potentially devastating condition, which puts the fetus at risk of bleeding. Thrombocytopenia is commonly defined as a platelet count <150 × 109/l. However, clinically significant bleeding problems are only likely to occur with platelet counts below 50 × 109/l (although some experts set this level at ≤30 × 109/l). The most feared and indeed morbid complication is intracranial hemorrhage (ICH), often associated with perinatal death or major neurological damage as a consequence.

Many fetomaternal and neonatal conditions are associated with thrombocytopenia (Table 7.1) [1].Thrombocytopenia with an immunological origin is encountered in 0.3% of the newborns [1–3]. Fetal and neonatal alloimmune thrombocytopenia (FNAIT) and idiopathic thrombocytopenic purpura (ITP) are the most important immune-mediated thrombocytopenias.

The focus in this chapter will be on FNAIT, which is one of the major causes of both severe thrombocytopenia and ICH in fetuses and term neonates.

FNAIT is caused by maternal immunization against human platelet antigens (HPAs) on fetal platelets, inherited from the father and different from those present in the mother. The IgG alloantibodies are transported through the placenta to the fetus, and cause destruction of fetal platelets. h is disease is the platelet equivalent of red cell alloimmunization. The resulting fetal thrombocytopenia is associated with risk of bleeding complications. The most feared complication is ICH and subsequent neurological morbidity or death.

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×